Physician profile
Sten E Kramer
NPI 1780783712
$10,637.75
in general payments reported to CMS, 2019-2025
39 companies · $1,248 in 2025
The $1,248 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,959 · 2020: $1,124 · 2021: $790 · 2022: $2,350 · 2023: $1,418 · 2024: $1,748 · 2025: $1,248.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,331 · Travel and Lodging: $50.51 · Education: $33.39.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,331.09 |
| Travel and Lodging | $50.51 |
| Education | $33.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,706.17 | 2019-2025 | Proclaim, Eterna |
| Spinal Simplicity, LLC | $1,232.49 | 2022-2023 | Ha Minuteman G3-R |
| Boston Scientific Corporation | $1,140.32 | 2020-2025 | Wavewriter Alpha Prime 16, General - Pain Management, Intracept |
| Medtronic USA, INC. | $830.97 | 2019-2020 | |
| Nevro Corp. | $520.16 | 2019-2023 | Senza |
| Mml US, INC. | $396.60 | 2024-2025 | Reactiv8 |
| Biotronik Nro, INC. | $309.15 | 2023-2024 | Prospera, Biotronik |
| Depuy Synthes Sales INC. | $283.67 | 2019-2025 | Monovisc, Orthovisc |
| Curonix LLC | $268.74 | 2023-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Painteq LLC | $247.61 | 2021-2024 | Painteq |
| Globus Medical, INC. | $169.30 | 2025 | Senza |
| Scilex Pharmaceuticals INC. | $134.66 | 2019-2021 | |
| Miach Orthopaedics, INC. | $126.11 | 2024 | |
| Pfizer INC. | $124.23 | 2019-2021 | |
| Stryker Corporation | $95.79 | 2024-2025 | Na, Alphavent, Cinchlock |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertos Medical, INC. | $95.14 | 2019-2021 | |
| Bioventus LLC | $90.16 | 2019-2023 | Exogen Ultrasound Bone Healing System |
| Kowa Pharmaceuticals America, INC. | $73.64 | 2023 | Seglentis |
| Fidia Pharma USA INC. | $70.61 | 2019-2025 | Hymovis, Triluron |
| Horizon Therapeutics Plc | $69.21 | 2019-2020 | |
| Vericel Corporation | $65.18 | 2021-2025 | Maci |
| Forte Bio-Pharma LLC | $63.53 | 2019-2024 | Prolate, Nalocet |
| Si-Bone, INC. | $57.73 | 2019-2024 | |
| Pacira Pharmaceuticals Incorporated | $56.53 | 2022-2023 | Zilretta, Iovera, Exparel |
| Zyla Life Sciences, INC. | $51.40 | 2019 | |
| Ge Healthcare | $47.67 | 2025 | |
| Orthogenrx INC. | $40.20 | 2019-2020 | |
| Stimwave Technologies Incorporated | $35.93 | 2019-2022 | |
| Averitas Pharma INC. | $30.00 | 2024 | Qutenza |
| Breg, INC | $24.78 | 2023 | Breg Vpulse, Plasmaflow, Polarcarewave |
| Ibsa Pharma INC. | $24.64 | 2022 | |
| Linvatec Corporation | $24.48 | 2019 | |
| Surgenex LLC | $22.17 | 2025 | Ardeograft, Renograft, Pellograft |
| Djo, LLC | $21.31 | 2023 | Donjoy, Aircast |
| Sanofi-Aventis U.S. LLC | $20.02 | 2022 | |
| Grt US Holding, INC. | $17.55 | 2022 | |
| Assertio Therapeutics, INC. | $17.30 | 2019 | |
| Relievant Medsystems, INC. | $16.80 | 2023 | Intracept |
| Pacira Therapeutics, INC. | $15.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sten Kramer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.